Amphastar Pharmaceuticals to Present at the Raymond James 2021 Institutional Healthcare Conference

RANCHO CUCAMONGA, Calif., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO, Dan Dischner, V.P of Corporate Communications and HR, Tony Marrs, Sr. V.P Regulatory Affairs and Clinical Operations, and Jacob Liawatidewi, Executive V.P. Corporate Administration Center and Sales & Marketing, will participate in an Analyst-Moderated fireside chat at the Raymond James 2021 Institutional Healthcare Conference on Tuesday, March 2, 2021 at 1:20 pm Eastern time.
This presentation will be made available webcast and may be accessed by visiting Amphastar Pharmaceuticals' website at This webcast will be available for 90 days following the presentation.About Amphastar:Amphastar is a specialty pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the Company sells insulin active pharmaceutical ingredient products. Most of the Companya??s finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers. More information is available at the Companya??s website at Amphastar Pharmaceuticalsa?? logo and other trademarks or service marks of Amphastar Pharmaceuticals,A Inc., including, but not limited to Primatene, Amphadase and Cortrosyn, are the property of Amphastar Pharmaceuticals,A Inc.
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Апрель 2021    »